SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-026034
Filing Date
2024-07-02
Accepted
2024-07-02 16:50:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 304072
2 form424b3_001.jpg GRAPHIC 2612
3 form424b3_002.jpg GRAPHIC 5193
  Complete submission text file 0001493152-24-026034.txt   316399
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280326 | Film No.: 241096451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)